OTTER PHARMACEUTICALS

Serial Number 97014255
606

Registration Progress

Application Filed
Sep 7, 2021
Under Examination
Sep 13, 2022
Approved for Publication
Jul 19, 2022
Published for Opposition
Jul 19, 2022
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: OTTER PHARMACEUTICALS
Previous Owner: Otter Pharmaceuticals, LLC
Classes: 005

Trademark Image

OTTER PHARMACEUTICALS

Basic Information

Serial Number
97014255
Filing Date
September 7, 2021
Published for Opposition
July 19, 2022
Abandonment Date
October 20, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 20, 2025
Classes
005

Rights Holder

Otter Pharmaceuticals, LLC

16
Address
Suite 300
100 S. Saunders Road
Lake Forest, IL 60045

Ownership History

Otter Pharmaceuticals, LLC

Original Applicant
16
Lake Forest, IL

Otter Pharmaceuticals, LLC

Owner at Publication
16
Lake Forest, IL

Legal Representation

Attorney
Tim Burgdorf

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

40 events
Date Code Type Description Documents
Oct 21, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Oct 20, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 19, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 19, 2025 EX5G S SOU EXTENSION 5 GRANTED Loading...
Mar 10, 2025 EXT5 S SOU EXTENSION 5 FILED Loading...
Mar 10, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 15, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 15, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 13, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Jan 13, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 14, 2024 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Oct 14, 2024 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Oct 14, 2024 PETG O PETITION TO REVIVE-GRANTED Loading...
Oct 14, 2024 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Oct 14, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Oct 14, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 13, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 12, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 12, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Mar 12, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 14, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 12, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 12, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Sep 12, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 4, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 2, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 2, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 2, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 13, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 19, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 19, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 29, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 13, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 13, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 13, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 13, 2022 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jun 13, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jun 10, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 17, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 10, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment and management of central nervous system diseases and disorders and neurological disorders; Pharmaceutical preparations for the relief, treatment or amelioration of pain; Analgesic preparations; Anti-inflammatories; Pharmaceutical preparations, namely, drug delivery systems comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"